Anikó Róka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anikó Róka has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Miklós Szabó
3 shared publicationsDenis Azzopardi
Neonatal Unit, Queen Charlotte’s and Chelsea Hospital, London, UK
2 shared publicationsEszter Bodrogi
First Department of Paediatrics, Semmelweis University, Budapest, Hungary
2 shared publicationsTamás Machay
First Department of Paediatrics, Semmelweis University, Budapest, Hungary
2 shared publicationsBarna Vásárhelyi
Research Group of Paediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary
1 shared publicationBarna Vásárhelyi
Research Group of Paediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary
1 shared publication
Latest Publications
- 2 November 2011
- Published by Wiley in Acta Paediatrica
- Vol. 101 (3) , 319-323
Serum S100B and neuron‐specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia
Aim: Serum S100B and neuron‐specific enolase (NSE) levels are elevated after perinatal asphyxia, but the influence of hypothermia on these proteins has not been previously reported. The aim of this study was to evaluate the effect of systemic hypothermia on these protein levels after perinatal asphyxia, time course, and association with perinatal factors and neurodevelopmental outcome at 2 years of age.Methods: Serum S100B and NSE levels were measured at fixed time points in asphyxiated infants treated with standard intensive care on hypothermia (HT: n = 13) or normothermia (NT: n = 11).Results: Serum S100B and NSE levels were grossly elevated in both HT and NT groups. Compared with the values at 6 h of age, S100B values decreased over time in both groups (NT: p = 0.002, HT: p = 0.04). Serum S100B values were lower in HT infants compared with those in NT infants (p = 0.047 at 48 h). Serum S100B and NSE values were significantly higher in infants who died or developed severe neurological impairment (S100B, p < 0.05 at all time points; NSE, p = 0.036 at 24 h of age).Conclusion: Both NSE and S100B levels are highly elevated following asphyxia. Serum S100B levels were lower in the HT group and strongly correlated with the neurodevelopmental outcome.
- 2 November 2011
- Published by Wiley in Acta Paediatrica
- Vol. 101 (3) , 319-323
Serum S100B and neuron‐specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia
Aim: Serum S100B and neuron‐specific enolase (NSE) levels are elevated after perinatal asphyxia, but the influence of hypothermia on these proteins has not been previously reported. The aim of this study was to evaluate the effect of systemic hypothermia on these protein levels after perinatal asphyxia, time course, and association with perinatal factors and neurodevelopmental outcome at 2 years of age.Methods: Serum S100B and NSE levels were measured at fixed time points in asphyxiated infants treated with standard intensive care on hypothermia (HT: n = 13) or normothermia (NT: n = 11).Results: Serum S100B and NSE levels were grossly elevated in both HT and NT groups. Compared with the values at 6 h of age, S100B values decreased over time in both groups (NT: p = 0.002, HT: p = 0.04). Serum S100B values were lower in HT infants compared with those in NT infants (p = 0.047 at 48 h). Serum S100B and NSE values were significantly higher in infants who died or developed severe neurological impairment (S100B, p < 0.05 at all time points; NSE, p = 0.036 at 24 h of age).Conclusion: Both NSE and S100B levels are highly elevated following asphyxia. Serum S100B levels were lower in the HT group and strongly correlated with the neurodevelopmental outcome.
- 30 November 2008
- Published by Elsevier in Early Human Development
- Vol. 84, S57
Serial proton MR spectroscopy measurement of cerebral metabolites in asphyxiated infants during the first week of life
- 30 November 2008
- Published by Elsevier in Early Human Development
- Vol. 84, S57
Serial proton MR spectroscopy measurement of cerebral metabolites in asphyxiated infants during the first week of life
- 1 April 2008
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 121 (4) , e844-e849
Elevated Morphine Concentrations in Neonates Treated With Morphine and Prolonged Hypothermia for Hypoxic Ischemic Encephalopathy
OBJECTIVES. Asphyxia and hypothermia may modify drug pharmacokinetics. We investigated whether analgesia with morphine in neonates with hypoxic ischemic encephalopathy undergoing prolonged moderate systemic hypothermia resulted in elevated serum morphine concentrations compared with normothermic infants. PATIENTS AND METHODS. Infants from 1 center participating in a multicenter randomized study of moderate whole-body hypothermia after perinatal asphyxia (the Total Body Hypothermia Study) were randomly selected for treatment with hypothermia (n = 10) or for standard care on normothermia (n = 6). Hypothermia (33°C to 34°C) was started before 6 hours of age and maintained for 72 hours. All of the infants were treated with a continuous infusion of morphine-hydrochloride, with the rate adjusted according to clinical status. Serum morphine concentrations were determined at 6, 12, 24, 48, and 72 hours after birth. RESULTS. Serum morphine concentrations at 24 to 72 hours after birth were (median [range]) 292 ng/mL (137–767 ng/mL) in the hypothermia-treated infants and 206 ng/mL (88–327 ng/mL) in the infants on normothermia, despite similar morphine infusion rates and cumulative doses. Morphine concentrations correlated with morphine infusion rate, cumulative dose, and treatment with hypothermia. Serum morphine concentrations reached a steady state after 24 hours in the normothermic infants but continued to increase throughout the assessment period in the hypothermia group. Morphine clearance was low in both groups: (median [range]) morphine clearance estimated from area under the curve was 0.69 mL/min per kg (0.58–1.21 mL/min per kg) in hypothermic group and 0.89 mL/min per kg (0.65–1.33 mL/min per kg) in infants on normothermia. Serum morphine concentrations >300 nL/mL occurred more often in the hypothermia group and when the morphine infusion rate was >10 μg/kg per h. CONCLUSIONS. Infants with hypoxic ischemic encephalopathy have reduced morphine clearance and elevated serum morphine concentrations when morphine infusion rates are based on clinical state. Potentially toxic serum concentrations of morphine may occur with moderate hypothermia and infusion rates >10 μg/kg per h.
- 1 April 2008
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 121 (4) , e844-e849
Elevated Morphine Concentrations in Neonates Treated With Morphine and Prolonged Hypothermia for Hypoxic Ischemic Encephalopathy
OBJECTIVES. Asphyxia and hypothermia may modify drug pharmacokinetics. We investigated whether analgesia with morphine in neonates with hypoxic ischemic encephalopathy undergoing prolonged moderate systemic hypothermia resulted in elevated serum morphine concentrations compared with normothermic infants. PATIENTS AND METHODS. Infants from 1 center participating in a multicenter randomized study of moderate whole-body hypothermia after perinatal asphyxia (the Total Body Hypothermia Study) were randomly selected for treatment with hypothermia (n = 10) or for standard care on normothermia (n = 6). Hypothermia (33°C to 34°C) was started before 6 hours of age and maintained for 72 hours. All of the infants were treated with a continuous infusion of morphine-hydrochloride, with the rate adjusted according to clinical status. Serum morphine concentrations were determined at 6, 12, 24, 48, and 72 hours after birth. RESULTS. Serum morphine concentrations at 24 to 72 hours after birth were (median [range]) 292 ng/mL (137–767 ng/mL) in the hypothermia-treated infants and 206 ng/mL (88–327 ng/mL) in the infants on normothermia, despite similar morphine infusion rates and cumulative doses. Morphine concentrations correlated with morphine infusion rate, cumulative dose, and treatment with hypothermia. Serum morphine concentrations reached a steady state after 24 hours in the normothermic infants but continued to increase throughout the assessment period in the hypothermia group. Morphine clearance was low in both groups: (median [range]) morphine clearance estimated from area under the curve was 0.69 mL/min per kg (0.58–1.21 mL/min per kg) in hypothermic group and 0.89 mL/min per kg (0.65–1.33 mL/min per kg) in infants on normothermia. Serum morphine concentrations >300 nL/mL occurred more often in the hypothermia group and when the morphine infusion rate was >10 μg/kg per h. CONCLUSIONS. Infants with hypoxic ischemic encephalopathy have reduced morphine clearance and elevated serum morphine concentrations when morphine infusion rates are based on clinical state. Potentially toxic serum concentrations of morphine may occur with moderate hypothermia and infusion rates >10 μg/kg per h.
- 23 July 2007
- Published by Wiley in Acta Paediatrica
- Vol. 96 (8) , 1118-1121
Changes in laboratory parameters indicating cell necrosis and organ dysfunction in asphyxiated neonates on moderate systemic hypothermia
Aim: Asphyxia is a major cause of morbidity and mortality in term infants. In addition to cerebral injury other organs are also distressed due to hypoxic‐ischaemic insult. Systemic hypothermia has a beneficial effect on brain injury. We tested the impact of hypothermia on hypoxic damage of other internal organs.Methods: Asphyxiated term neonates (n = 21) were randomised to groups treated with hypothermia (n = 12) and normothermia (n = 9). Hypothermia (33–34°C) was initiated within 6 h of life, and maintained for 72 h. We determined serum transaminase, lactate dehydrogenase, creatine kinase, uric acid, creatinine levels and diuresis during 6, 24, 48 and 72 postnatal hours.Results: Area under curve values of aspartate aminotransferase (ASAT), lactate dehydrogenase (LDH), uric acid and creatinine during the investigated period and alanine aminotransferase (ALAT) value at 72 h were lower in neonates on hypothermia than in those on normothermia. Renal failure and liver impairment affected less hypothermic than normothermic neonates (3/12 vs. 7/9, p = 0.03, 3/12 vs. 6/9 p = 0.08, respectively). Four of the 12 hypothermic and 6 of the 9 normothermic neonates developed multiorgan failure.Conclusions: These results suggest that systemic hypothermia may protect against cell necrosis and tissue dysfunction of internal organs after neonatal asphyxia.
- 23 July 2007
- Published by Wiley in Acta Paediatrica
- Vol. 96 (8) , 1118-1121
Changes in laboratory parameters indicating cell necrosis and organ dysfunction in asphyxiated neonates on moderate systemic hypothermia
Aim: Asphyxia is a major cause of morbidity and mortality in term infants. In addition to cerebral injury other organs are also distressed due to hypoxic‐ischaemic insult. Systemic hypothermia has a beneficial effect on brain injury. We tested the impact of hypothermia on hypoxic damage of other internal organs.Methods: Asphyxiated term neonates (n = 21) were randomised to groups treated with hypothermia (n = 12) and normothermia (n = 9). Hypothermia (33–34°C) was initiated within 6 h of life, and maintained for 72 h. We determined serum transaminase, lactate dehydrogenase, creatine kinase, uric acid, creatinine levels and diuresis during 6, 24, 48 and 72 postnatal hours.Results: Area under curve values of aspartate aminotransferase (ASAT), lactate dehydrogenase (LDH), uric acid and creatinine during the investigated period and alanine aminotransferase (ALAT) value at 72 h were lower in neonates on hypothermia than in those on normothermia. Renal failure and liver impairment affected less hypothermic than normothermic neonates (3/12 vs. 7/9, p = 0.03, 3/12 vs. 6/9 p = 0.08, respectively). Four of the 12 hypothermic and 6 of the 9 normothermic neonates developed multiorgan failure.Conclusions: These results suggest that systemic hypothermia may protect against cell necrosis and tissue dysfunction of internal organs after neonatal asphyxia.
- 1 May 2007
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 148 (21) , 993-998
Whole body hypothermia for the treatment of hypoxic-ischaemic encephalopathy in term infants – a safety study in Hungary
Az asphyxiát elszenvedett újszülöttek kezelésében ígéretes lehetőség a mérsékelt, teljestest-hypothermia, amely több támadásponton képes csökkenteni a hypoxia-ischaemia által beindított biokémiai kaszkádot, valamint a maradandó szervkárosodást. Célkitűzés: A vizsgálat célja az volt, hogy egy nagy esetszámú hatékonysági vizsgálatot megelőzően felmérje a mérsékelt teljestest-hypothermia biztonságosságát és technikai kivitelezhetőségét Magyarországon. Módszer: Nyitott, prospektív „esetsorozat” klinikai vizsgálat keretében 2003 októberétől 2005 januárjáig a Semmelweis Egyetem I. Gyermekgyógyászati Klinika NIC osztályán 28 érett asphyxiás újszülöttnél alkalmaztak hypothermiás kezelést, melyhez 23, korábban (1996 és 2002 közötti időszakban) kezelt, klinikai paramétereikben hasonló újszülöttet választottak történelmi kontrollként. Beválasztási kritériumok: 5 perces Apgar-érték: ≤5, emellett felvételkor BE: ≤ –15 mmol/l és hypoxiás-ischaemiás encephalopathiára jellemző neurológiai tünetek jelenléte egyidejűleg. A mérsékelt, egésztest-hypothermiát (maghő: 33,0–34,0 °C) folyamatos morfin analgézia mellett 72 órán keresztül tartották fenn. Az intenzív kezelés alatt laboratóriumi vizsgálatok, szeriális koponya-UH, valamint standard intenzív terápiás monitorozás történt. A vizsgálat során összehasonlították a mortalitást, durva neurológiai maradványtünetek előfordulását, és az előre meghatározott klinikai paramétereket. Eredmények: A két csoport antropometriai adatai és iniciális klinikai állapota (Apgar, pH, BE, encephalopathia tünetei) szignifikánsan nem különbözött. A hypothermiás (10/28) és a kontrollcsoport (10/21) mortalitásában nem találtak különbséget. A vizsgált klinikai paraméterekben (laboratóriumi paraméterek, ultrahang-eltérések, hypoglykaemia, vérzékenység, súlyos hipotenzió előfordulása, katecholamin-igény, oliguria) és a 1,5–2 éves utánkövetés során észlelt idegrendszeri károsodás arányaiban szignifikáns különbség nem igazolódott. A hypothermiával oki összefüggésbe hozható mellékhatást nem észleltek. Következtetés: A mérsékelt, egésztest-hypothermia a vizsgálat szerint biztonsággal alkalmazható, nem fokozza a súlyos perinatalis asphyxiát elszenvedett újszülöttek mortalitását és morbiditását. A hatásosság megítélésére további, széles nemzetközi összefogáson alapuló nagy esetszámú randomizált klinikai vizsgálatra van szükség.
- 1 May 2007
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 148 (21) , 993-998
Whole body hypothermia for the treatment of hypoxic-ischaemic encephalopathy in term infants – a safety study in Hungary
Az asphyxiát elszenvedett újszülöttek kezelésében ígéretes lehetőség a mérsékelt, teljestest-hypothermia, amely több támadásponton képes csökkenteni a hypoxia-ischaemia által beindított biokémiai kaszkádot, valamint a maradandó szervkárosodást. Célkitűzés: A vizsgálat célja az volt, hogy egy nagy esetszámú hatékonysági vizsgálatot megelőzően felmérje a mérsékelt teljestest-hypothermia biztonságosságát és technikai kivitelezhetőségét Magyarországon. Módszer: Nyitott, prospektív „esetsorozat” klinikai vizsgálat keretében 2003 októberétől 2005 januárjáig a Semmelweis Egyetem I. Gyermekgyógyászati Klinika NIC osztályán 28 érett asphyxiás újszülöttnél alkalmaztak hypothermiás kezelést, melyhez 23, korábban (1996 és 2002 közötti időszakban) kezelt, klinikai paramétereikben hasonló újszülöttet választottak történelmi kontrollként. Beválasztási kritériumok: 5 perces Apgar-érték: ≤5, emellett felvételkor BE: ≤ –15 mmol/l és hypoxiás-ischaemiás encephalopathiára jellemző neurológiai tünetek jelenléte egyidejűleg. A mérsékelt, egésztest-hypothermiát (maghő: 33,0–34,0 °C) folyamatos morfin analgézia mellett 72 órán keresztül tartották fenn. Az intenzív kezelés alatt laboratóriumi vizsgálatok, szeriális koponya-UH, valamint standard intenzív terápiás monitorozás történt. A vizsgálat során összehasonlították a mortalitást, durva neurológiai maradványtünetek előfordulását, és az előre meghatározott klinikai paramétereket. Eredmények: A két csoport antropometriai adatai és iniciális klinikai állapota (Apgar, pH, BE, encephalopathia tünetei) szignifikánsan nem különbözött. A hypothermiás (10/28) és a kontrollcsoport (10/21) mortalitásában nem találtak különbséget. A vizsgált klinikai paraméterekben (laboratóriumi paraméterek, ultrahang-eltérések, hypoglykaemia, vérzékenység, súlyos hipotenzió előfordulása, katecholamin-igény, oliguria) és a 1,5–2 éves utánkövetés során észlelt idegrendszeri károsodás arányaiban szignifikáns különbség nem igazolódott. A hypothermiával oki összefüggésbe hozható mellékhatást nem észleltek. Következtetés: A mérsékelt, egésztest-hypothermia a vizsgálat szerint biztonsággal alkalmazható, nem fokozza a súlyos perinatalis asphyxiát elszenvedett újszülöttek mortalitását és morbiditását. A hatásosság megítélésére további, széles nemzetközi összefogáson alapuló nagy esetszámú randomizált klinikai vizsgálatra van szükség.